Desvenlafaxine Tablet, Extended Release
Product Images NDC 46708-153

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Desvenlafaxine (NDC 46708-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desvenlafaxine-100mg.jpg (Desvenlafaxine 100mg)

Label for Desvenlafaxine Extended-Release Tablets 100 mg by Alembic Pharmaceuticals Limited. The oral tablets come in a package of 30 tablets. Storage instructions indicate keeping at 20° to 25°C with allowed excursions. The label includes NDC 46708-153-30, barcode, and dispensing information.*

FDA Label Image

Figure 1 (Desvenlafaxine 1figure)

A pharmacokinetic chart titled 'Impact of other drugs on Desvenlafaxine Pharmacokinetics (PK)' showing the effect of CYP3A4 inhibitors, specifically Ketoconazole, on Desvenlafaxine's Cmax and AUC values. The chart plots fold change and 90% confidence intervals relative to reference values, with a recommendation indicating no dose adjustment needed.*

FDA Label Image

Figure 2 (Desvenlafaxine 2figure)

A pharmacokinetics impact chart showing how Desvenlafaxine at doses of 50 mg, 100 mg, and 400 mg affects the Cmax and AUC of interacting drugs Desipramine, Midazolam, Tamoxifen, and Aripiprazole. The chart displays fold change and 90% confidence intervals relative to reference, along with dosage adjustment recommendations.*

FDA Label Image

Figure 3 (Desvenlafaxine 3figure)

A figure illustrating the impact of intrinsic factors such as renal impairment, hepatic impairment, and population description on pharmacokinetics (Cmax and AUC) of Desvenlafaxine. The chart shows fold change and 90% confidence intervals relative to reference values, with dosing recommendations based on severity of impairment and patient demographics.*

FDA Label Image

Desvenlafaxine-50mg.jpg (Desvenlafaxine 50mg)

Desvenlafaxine Extended-Release Tablets 50 mg oral tablets in a package containing 30 tablets. Label shows the product is manufactured by Alembic Pharmaceuticals Limited and includes storage instructions, a barcode, and NDC 46708-152-30. The label highlights the dosage strength and a pharmacist advisory to dispense the accompanying guide to patients.*

FDA Label Image

Structure (Desvenlafaxine Str)

Chemical structure diagram of desvenlafaxine, showing its molecular framework with a cyclohexanol group, a hydroxylated aromatic ring, and a dimethylaminoethyl side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.